Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Autoimmune Disorders

  Free Subscription


Articles published in J Autoimmun

Retrieve available abstracts of 289 articles:
HTML format



Single Articles


    September 2021
  1. RELA M, Jothimani D, Vij M, Rajakumar A, et al
    Auto-immune hepatitis following COVID vaccination.
    J Autoimmun. 2021;123:102688.
    PubMed     Abstract available


  2. BOGIE JFJ, Vanmierlo T, Vanmol J, Timmermans S, et al
    Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner.
    J Autoimmun. 2021;124:102723.
    PubMed     Abstract available


    August 2021
  3. LEE AYS, Reed JH, Gordon TP
    Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
    J Autoimmun. 2021;124:102724.
    PubMed     Abstract available


  4. HIRSIGER JR, Tamborrini G, Harder D, Bantug GR, et al
    Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination.
    J Autoimmun. 2021;124:102714.
    PubMed     Abstract available


  5. HEMED-SHAKED M, Cowman MK, Kim JR, Huang X, et al
    MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A.
    J Autoimmun. 2021;124:102713.
    PubMed     Abstract available


  6. HANSEN RB, Simard JF, Faurschou M, Jacobsen S, et al
    Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population.
    J Autoimmun. 2021;123:102692.
    PubMed     Abstract available


  7. LU Q, Long H, Chow S, Hidayat S, et al
    Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
    J Autoimmun. 2021;123:102707.
    PubMed     Abstract available


    July 2021
  8. VUILLE-LESSARD E, Montani M, Bosch J, Semmo N, et al
    Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    J Autoimmun. 2021;123:102710.
    PubMed     Abstract available


  9. ZHOU S, Li Q, Zhou S, Zhao M, et al
    A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells.
    J Autoimmun. 2021;123:102686.
    PubMed     Abstract available


  10. IBANEZ-VEGA J, Vilchez C, Jimenez K, Guevara C, et al
    Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
    J Autoimmun. 2021;123:102702.
    PubMed     Abstract available


  11. BAKASIS AD, Mavragani CP, Boki KA, Tzioufas AG, et al
    COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    J Autoimmun. 2021;123:102687.
    PubMed     Abstract available


  12. GHIELMETTI M, Schaufelberger HD, Mieli-Vergani G, Cerny A, et al
    Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    J Autoimmun. 2021;123:102706.
    PubMed     Abstract available


  13. GRAVER JC, Abdulahad W, van der Geest KSM, Heeringa P, et al
    Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
    J Autoimmun. 2021;123:102684.
    PubMed     Abstract available


  14. REN HM, Lukacher AE, Rahman ZSM, Olsen NJ, et al
    New developments implicating IL-21 in autoimmune disease.
    J Autoimmun. 2021;122:102689.
    PubMed     Abstract available


  15. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Corrigendum to "Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis" [J. Autoimmun. 119C (2021) 102629].
    J Autoimmun. 2021;121:102665.
    PubMed    


  16. MCGONAGLE D, De Marco G, Bridgewood C
    Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    J Autoimmun. 2021;121:102662.
    PubMed     Abstract available


  17. DOTAN A, Shoenfeld Y
    Perspectives on vaccine induced thrombotic thrombocytopenia.
    J Autoimmun. 2021;121:102663.
    PubMed     Abstract available


    June 2021
  18. LINGEL H, Meltendorf S, Billing U, Thurm C, et al
    Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
    J Autoimmun. 2021;122:102682.
    PubMed     Abstract available


  19. DIANA T, Ungerer M, Wuster C, Fassbender J, et al
    A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
    J Autoimmun. 2021;122:102666.
    PubMed     Abstract available


  20. GU Y, Merriman C, Guo Z, Jia X, et al
    Novel autoantibodies to the beta-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
    J Autoimmun. 2021;122:102677.
    PubMed     Abstract available


  21. RODRIGUEZ-PEREZ AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al
    Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
    J Autoimmun. 2021;122:102683.
    PubMed     Abstract available


  22. KRILIS M, Qi M, Ioannou Y, Zhang JY, et al
    Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
    J Autoimmun. 2021;122:102675.
    PubMed     Abstract available


  23. KJELDSEN J, Nielsen J, Ellingsen T, Knudsen T, et al
    Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark.
    J Autoimmun. 2021;120:102632.
    PubMed     Abstract available


    May 2021
  24. NISHIMURA T, Okayasu T, Hosoi H, Kitahara T, et al
    Long-term (16-26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss.
    J Autoimmun. 2021;121:102664.
    PubMed     Abstract available


  25. TAKESHITA M, Suzuki K, Nakazawa M, Kamata H, et al
    Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease.
    J Autoimmun. 2021;121:102661.
    PubMed     Abstract available


  26. GRAHAM JJ, Longhi MS, Heneghan MA
    T helper cell immunity in pregnancy and influence on autoimmune disease progression.
    J Autoimmun. 2021;121:102651.
    PubMed     Abstract available


  27. GHESQUIERE T, Ciudad M, Ramon A, Greigert H, et al
    Mucosal-associated invariant T cells in Giant Cell Arteritis.
    J Autoimmun. 2021;121:102652.
    PubMed     Abstract available


  28. KIM JS, Kim IH, Byun JM, Chang JH, et al
    Population-based study on the association between autoimmune disease and lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.
    J Autoimmun. 2021;121:102647.
    PubMed     Abstract available


    April 2021
  29. VALENTI L, Griffini S, Lamorte G, Grovetti E, et al
    Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595].
    J Autoimmun. 2021;120:102646.
    PubMed    


  30. WILHELM M, Bonam SR, Schall N, Bendorius M, et al
    Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus.
    J Autoimmun. 2021;120:102633.
    PubMed     Abstract available


  31. WANG JY, Zhang W, Roehrl MW, Roehrl VB, et al
    An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
    J Autoimmun. 2021;120:102644.
    PubMed     Abstract available


  32. VAN WIGCHEREN GF, Roelofs D, Figdor CG, Florez-Grau G, et al
    Three distinct tolerogenic CD14(+) myeloid cell types to actively manage autoimmune disease: Opportunities and challenges.
    J Autoimmun. 2021;120:102645.
    PubMed     Abstract available


    March 2021
  33. HALPERT G, Watad A, Tsur AM, Dotan A, et al
    Autoimmune dysautonomia in women with silicone breast implants.
    J Autoimmun. 2021;120:102631.
    PubMed     Abstract available


  34. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis.
    J Autoimmun. 2021;119:102629.
    PubMed     Abstract available


    February 2021
  35. LONGHI MS, Mieli-Vergani G, Vergani D
    Regulatory T cells in autoimmune hepatitis: Un updated overview.
    J Autoimmun. 2021;119:102619.
    PubMed     Abstract available


  36. PALM AE, Kleinau S
    Marginal zone B cells: From housekeeping function to autoimmunity?
    J Autoimmun. 2021;119:102627.
    PubMed     Abstract available


  37. KHOSRAVI-MAHARLOOEI M, Li H, Hoelzl M, Zhao G, et al
    Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice.
    J Autoimmun. 2021;119:102612.
    PubMed     Abstract available


    January 2021
  38. MOLDOVEANU Z, Suzuki H, Reily C, Satake K, et al
    Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    J Autoimmun. 2021;118:102593.
    PubMed     Abstract available


    December 2020
  39. BUITRAGO-MOLINA LE, Pietrek J, Noyan F, Schlue J, et al
    Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
    J Autoimmun. 2020;117:102591.
    PubMed     Abstract available


  40. NOVELLI L, Motta F, De Santis M, Ansari AA, et al
    The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
    J Autoimmun. 2020;117:102592.
    PubMed     Abstract available


    November 2020
  41. SARMIENTO-MONROY JC, Espinosa G, Londono MC, Meira F, et al
    A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.
    J Autoimmun. 2020;117:102580.
    PubMed     Abstract available


  42. ALBORZIAN DEH SHEIKH A, Gomaa S, Li X, Routledge M, et al
    A Guillain-Barre syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides.
    J Autoimmun. 2020 Nov 19:102571. doi: 10.1016/j.jaut.2020.102571.
    PubMed     Abstract available


    September 2020
  43. GORABI AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, et al
    Corrigendum to "The pivotal role of CD69 in autoimmunity" [J. Autoimmun. 111C (2020) 102453].
    J Autoimmun. 2020 Sep 30:102548. doi: 10.1016/j.jaut.2020.102548.
    PubMed    


  44. GOKHALE AS, Gangaplara A, Lopez-Occasio M, Thornton AM, et al
    Corrigendum to "Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity" [J. Autoimmun. 105C (2019) 102300].
    J Autoimmun. 2020 Sep 24:102544. doi: 10.1016/j.jaut.2020.102544.
    PubMed    


  45. CALABRESE LH, Caporali R, Blank CU, Kirk AD, et al
    Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.
    J Autoimmun. 2020 Sep 23:102546. doi: 10.1016/j.jaut.2020.102546.
    PubMed     Abstract available


  46. ZHAO Y, Wei W, Liu ML
    Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications.
    J Autoimmun. 2020 Sep 4:102540. doi: 10.1016/j.jaut.2020.102540.
    PubMed     Abstract available


    August 2020
  47. GORABI AM, Kiaie N, Aslani S, Jamialahmadi T, et al
    Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight.
    J Autoimmun. 2020 Aug 8:102529. doi: 10.1016/j.jaut.2020.102529.
    PubMed     Abstract available


    July 2020
  48. PATSOURAS M, Tsiki E, Karagianni P, Vlachoyiannopoulos PG, et al
    The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome.
    J Autoimmun. 2020 Jul 21:102527. doi: 10.1016/j.jaut.2020.102527.
    PubMed     Abstract available


  49. MARZIALE A, Bettacchioli E, Picart G, Nafai S, et al
    Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases.
    J Autoimmun. 2020 Jul 18:102524. doi: 10.1016/j.jaut.2020.102524.
    PubMed     Abstract available


  50. LIU Y, Wang J, Luo S, Zhan Y, et al
    The roles of PPARgamma and its agonists in autoimmune diseases: A comprehensive review.
    J Autoimmun. 2020 Jul 1:102510. doi: 10.1016/j.jaut.2020.102510.
    PubMed     Abstract available


    June 2020
  51. THOME R, Casella G, Lotfi N, Ishikawa LWL, et al
    Primaquine elicits Foxp3(+) regulatory T cells with a superior ability to limit CNS autoimmune inflammation.
    J Autoimmun. 2020 Jun 25:102505. doi: 10.1016/j.jaut.2020.102505.
    PubMed     Abstract available


  52. BING SJ, Silver PB, Jittayasothorn Y, Mattapallil MJ, et al
    Autoimmunity to neuroretina in the concurrent absence of IFN-gamma and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation.
    J Autoimmun. 2020 Jun 24:102507. doi: 10.1016/j.jaut.2020.102507.
    PubMed     Abstract available


  53. THAM EL, Freeley SJ, Bearder S, Barros FF, et al
    VISTA deficiency protects from immune complex-mediated glomerulonephritis by inhibiting neutrophil activation.
    J Autoimmun. 2020 Jun 22:102501. doi: 10.1016/j.jaut.2020.102501.
    PubMed     Abstract available


  54. HU S, Liu X, Li T, Li Z, et al
    LAG3 (CD223) and autoimmunity: Emerging evidence.
    J Autoimmun. 2020 Jun 20:102504. doi: 10.1016/j.jaut.2020.102504.
    PubMed     Abstract available


  55. DANG J, Xu Z, Xu A, Liu Y, et al
    Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39(-)CD73 signaling pathway.
    J Autoimmun. 2020 Jun 18:102491. doi: 10.1016/j.jaut.2020.102491.
    PubMed     Abstract available


  56. EFRAIM Y, Chen FYT, Stashko C, Cheong KN, et al
    Alterations in corneal biomechanics underlie early stages of autoimmune-mediated dry eye disease.
    J Autoimmun. 2020 Jun 18:102500. doi: 10.1016/j.jaut.2020.102500.
    PubMed     Abstract available


  57. RODRIGUEZ Y, Novelli L, Rojas M, De Santis M, et al
    Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.
    J Autoimmun. 2020 Jun 16:102506. doi: 10.1016/j.jaut.2020.102506.
    PubMed     Abstract available


  58. ZHOU X, Kailemia MJ, Sun Y, Shuai Z, et al
    Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis.
    J Autoimmun. 2020 Jun 13:102503. doi: 10.1016/j.jaut.2020.102503.
    PubMed     Abstract available


  59. ZEN M, Fuzzi E, Astorri D, Saccon F, et al
    SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    J Autoimmun. 2020 Jun 8:102502. doi: 10.1016/j.jaut.2020.102502.
    PubMed     Abstract available


  60. WONG HY, Schwarz H
    CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
    J Autoimmun. 2020 Jun 4:102499. doi: 10.1016/j.jaut.2020.102499.
    PubMed     Abstract available


  61. WONG ASL, Gruber DR, Richards AL, Sheldon K, et al
    Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity.
    J Autoimmun. 2020 Jun 2:102489. doi: 10.1016/j.jaut.2020.102489.
    PubMed     Abstract available


    May 2020
  62. KOMICI K, Faris P, Negri S, Rosti V, et al
    Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca(2+) signaling: A novel approach for an old disease.
    J Autoimmun. 2020 May 29:102486. doi: 10.1016/j.jaut.2020.102486.
    PubMed     Abstract available


  63. COLASANTI T, Sabatinelli D, Mancone C, Giorgi A, et al
    Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients.
    J Autoimmun. 2020 May 27:102470. doi: 10.1016/j.jaut.2020.102470.
    PubMed     Abstract available


  64. DE BONT CM, Stokman MEM, Faas P, Thurlings RM, et al
    Autoantibodies to neutrophil extracellular traps represent a potential serological biomarker in rheumatoid arthritis.
    J Autoimmun. 2020 May 22:102484. doi: 10.1016/j.jaut.2020.102484.
    PubMed     Abstract available


  65. YANG Y, Peng F, Wang R, Yang M, et al
    Corrigendum to "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China" [J. Autoimmun. 109C (2020) 102434].
    J Autoimmun. 2020 May 15:102487. doi: 10.1016/j.jaut.2020.102487.
    PubMed    


  66. CARL PL, Fried HM, Cohen PL
    Proteins in assemblages formed by phase separation possess properties that promote their transformation to autoantigens: Implications for autoimmunity.
    J Autoimmun. 2020 May 11:102471. doi: 10.1016/j.jaut.2020.102471.
    PubMed     Abstract available


    April 2020
  67. ZHANG D, Kinloch AJ, Srinath A, Shenkar R, et al
    Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.
    J Autoimmun. 2020 Apr 30:102469. doi: 10.1016/j.jaut.2020.102469.
    PubMed     Abstract available


  68. LONG D, Chen Y, Wu H, Zhao M, et al
    Corrigendum to "Clinical Significance and Immunobiology of IL-21 in Autoimmunity"[J. Autoimmun. 99C (2019) p1-14].
    J Autoimmun. 2020 Apr 28:102455. doi: 10.1016/j.jaut.2020.102455.
    PubMed    


  69. ZHANG X, Olsen N, Zheng SG
    The progress and prospect of regulatory T cells in autoimmune diseases.
    J Autoimmun. 2020 Apr 15:102461. doi: 10.1016/j.jaut.2020.102461.
    PubMed     Abstract available


  70. GORABI AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, et al
    The pivotal role of CD69 in autoimmunity.
    J Autoimmun. 2020 Apr 11:102453. doi: 10.1016/j.jaut.2020.102453.
    PubMed     Abstract available


  71. LEVITE M, Zelig D, Friedman A, Ilouz N, et al
    Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    J Autoimmun. 2020 Apr 10:102462. doi: 10.1016/j.jaut.2020.102462.
    PubMed     Abstract available


  72. GATTO M, Radu CM, Luisetto R, Ghirardello A, et al
    Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings.
    J Autoimmun. 2020 Apr 4:102443. doi: 10.1016/j.jaut.2020.102443.
    PubMed     Abstract available


    March 2020
  73. BAE HR, Leung PSC, Hodge DL, Fenimore JM, et al
    Multi-omics: Differential expression of IFN-gamma results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases.
    J Autoimmun. 2020 Mar 24:102436. doi: 10.1016/j.jaut.2020.102436.
    PubMed     Abstract available


  74. MUHAMMAD F, Wang D, McDonald T, Walsh M, et al
    TIGIT(+) A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis.
    J Autoimmun. 2020 Mar 20:102441. doi: 10.1016/j.jaut.2020.102441.
    PubMed     Abstract available


  75. ZHANG L, Wu H, Zhao M, Chang C, et al
    Clinical significance of miRNAs in autoimmunity.
    J Autoimmun. 2020 Mar 14:102438. doi: 10.1016/j.jaut.2020.102438.
    PubMed     Abstract available


    February 2020
  76. ZHOU M, Guo C, Li X, Huang Y, et al
    JAK/STAT signaling controls the fate of CD8(+)CD103(+) tissue-resident memory T cell in lupus nephritis.
    J Autoimmun. 2020 Feb 18:102424. doi: 10.1016/j.jaut.2020.102424.
    PubMed     Abstract available


  77. XU Y, Fang D
    Endoplasmic reticulum-associated degradation and beyond: The multitasking roles for HRD1 in immune regulation and autoimmunity.
    J Autoimmun. 2020 Feb 10:102423. doi: 10.1016/j.jaut.2020.102423.
    PubMed     Abstract available


  78. JOHNSON BM, Gaudreau MC, Gudi R, Brown R, et al
    Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice.
    J Autoimmun. 2020 Feb 1:102420. doi: 10.1016/j.jaut.2020.102420.
    PubMed     Abstract available


    January 2020
  79. LI CW, Osman R, Menconi F, Concepcion E, et al
    Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
    J Autoimmun. 2020 Jan 21:102402. doi: 10.1016/j.jaut.2020.102402.
    PubMed     Abstract available


  80. MALVIYA M, Saoudi A, Bauer J, Fillatreau S, et al
    Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells.
    J Autoimmun. 2020 Jan 13:102401. doi: 10.1016/j.jaut.2020.102401.
    PubMed     Abstract available


  81. NAKANE S, Mukaino A, Higuchi O, Yasuhiro M, et al
    A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy.
    J Autoimmun. 2020 Jan 7:102403. doi: 10.1016/j.jaut.2020.102403.
    PubMed     Abstract available


  82. VAN DELFT MAM, Huizinga TWJ
    An overview of autoantibodies in rheumatoid arthritis.
    J Autoimmun. 2020 Jan 3:102392. doi: 10.1016/j.jaut.2019.102392.
    PubMed     Abstract available


  83. MENG J, Liu X, Zhang P, Li D, et al
    Corrigendum to "Rb selectively inhibits innate IFN-beta production by enhancing deacetylation of IFN-beta promoter through HDAC1 and HDAC8" [J. Autoimmun. 73C (2016) 42-53].
    J Autoimmun. 2020;106:102380.
    PubMed    


    December 2019
  84. SAFERDING V, Bluml S
    Innate immunity as the trigger of systemic autoimmune diseases.
    J Autoimmun. 2019 Dec 26:102382. doi: 10.1016/j.jaut.2019.102382.
    PubMed     Abstract available


  85. WATANABE-KUSUNOKI K, Nakazawa D, Kusunoki Y, Kudo T, et al
    Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
    J Autoimmun. 2019 Dec 26:102390. doi: 10.1016/j.jaut.2019.102390.
    PubMed     Abstract available


  86. HUANG C, Yi X, Long H, Zhang G, et al
    Disordered cutaneous microbiota in systemic lupus erythematosus.
    J Autoimmun. 2019 Dec 26:102391. doi: 10.1016/j.jaut.2019.102391.
    PubMed     Abstract available


  87. SCHEINECKER C, Goschl L, Bonelli M
    Treg cells in health and autoimmune diseases: New insights from single cell analysis.
    J Autoimmun. 2019 Dec 17:102376. doi: 10.1016/j.jaut.2019.102376.
    PubMed     Abstract available


  88. SUTO T, Karonitsch T
    The immunobiology of mTOR in autoimmunity.
    J Autoimmun. 2019 Dec 9:102373. doi: 10.1016/j.jaut.2019.102373.
    PubMed     Abstract available


  89. SABOURI S, Benkahla MA, Kiosses WB, Rodriguez-Calvo T, et al
    Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.
    J Autoimmun. 2019 Dec 6:102378. doi: 10.1016/j.jaut.2019.102378.
    PubMed     Abstract available


  90. ARINGER M
    Inflammatory markers in systemic lupus erythematosus.
    J Autoimmun. 2019 Dec 4:102374. doi: 10.1016/j.jaut.2019.102374.
    PubMed     Abstract available


  91. PISETSKY DS
    Evolving story of autoantibodies in systemic lupus erythematosus.
    J Autoimmun. 2019 Dec 3:102356. doi: 10.1016/j.jaut.2019.102356.
    PubMed     Abstract available


  92. CATALINA MD, Owen KA, Labonte AC, Grammer AC, et al
    The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus.
    J Autoimmun. 2019 Dec 2:102359. doi: 10.1016/j.jaut.2019.102359.
    PubMed     Abstract available


    November 2019
  93. CHANG CB, Lee SP, Chen WM, Wang CM, et al
    Dendritic cell upregulation of programmed death ligand-1 via DNA demethylation inhibits experimental autoimmune encephalomyelitis.
    J Autoimmun. 2019 Nov 28:102362. doi: 10.1016/j.jaut.2019.102362.
    PubMed     Abstract available


  94. FU J, Shi H, Wang B, Zhan T, et al
    LncRNA PVT1 links Myc to glycolytic metabolism upon CD4(+) T cell activation and Sjogren's syndrome-like autoimmune response.
    J Autoimmun. 2019 Nov 19:102358. doi: 10.1016/j.jaut.2019.102358.
    PubMed     Abstract available


  95. ANDRIANOVA IA, Ponomareva AA, Mordakhanova ER, Le Minh G, et al
    In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation.
    J Autoimmun. 2019 Nov 12:102355. doi: 10.1016/j.jaut.2019.102355.
    PubMed     Abstract available


    October 2019
  96. ESSOUMA M, Nkeck JR, Endomba FT, Bigna JJ, et al
    Systemic lupus erythematosus in Native sub-Saharan Africans: A systematic review and meta-analysis.
    J Autoimmun. 2019 Oct 23:102348. doi: 10.1016/j.jaut.2019.102348.
    PubMed     Abstract available


  97. ENOCSSON H, Wirestam L, Dahle C, Padyukov L, et al
    Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
    J Autoimmun. 2019 Oct 17:102340. doi: 10.1016/j.jaut.2019.102340.
    PubMed     Abstract available


  98. ALEXOPOULOS H, Dalakas MC
    The immunobiology of autoimmune encephalitides.
    J Autoimmun. 2019 Oct 11:102339. doi: 10.1016/j.jaut.2019.102339.
    PubMed     Abstract available


  99. LOUROU N, Gavriilidis M, Kontoyiannis DL
    Lessons from studying the AU-rich elements in chronic inflammation and autoimmunity.
    J Autoimmun. 2019 Oct 8:102334. doi: 10.1016/j.jaut.2019.102334.
    PubMed     Abstract available


  100. LEFEUVRE CM, Payet CA, Fayet OM, Maillard S, et al
    Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers.
    J Autoimmun. 2019 Oct 5:102337. doi: 10.1016/j.jaut.2019.102337.
    PubMed     Abstract available


    September 2019
  101. HUANG C, Zhu HX, Yao Y, Bian ZH, et al
    Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases.
    J Autoimmun. 2019 Sep 26:102333. doi: 10.1016/j.jaut.2019.102333.
    PubMed     Abstract available


  102. KATSIOUGIANNIS S, Tenta R, Skopouli FN
    Autoimmune epithelitis (Sjogren's syndrome); the impact of metabolic status of glandular epithelial cells on auto-immunogenicity.
    J Autoimmun. 2019 Sep 17:102335. doi: 10.1016/j.jaut.2019.102335.
    PubMed     Abstract available


  103. JOG NR, McClain MT, Heinlen LD, Gross T, et al
    Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
    J Autoimmun. 2019 Sep 9:102332. doi: 10.1016/j.jaut.2019.102332.
    PubMed     Abstract available


  104. SUNG SJ, Fu SM
    Interactions among glomerulus infiltrating macrophages and intrinsic cells via cytokines in chronic lupus glomerulonephritis.
    J Autoimmun. 2019 Sep 5:102331. doi: 10.1016/j.jaut.2019.102331.
    PubMed     Abstract available


    August 2019
  105. VLACHIOTIS S, Andreakos E
    Lambda interferons in immunity and autoimmunity.
    J Autoimmun. 2019 Aug 31:102319. doi: 10.1016/j.jaut.2019.102319.
    PubMed     Abstract available


  106. NEZOS A, Evangelopoulos ME, Mavragani CP
    Genetic contributors and soluble mediators in prediction of autoimmune comorbidity.
    J Autoimmun. 2019 Aug 20:102317. doi: 10.1016/j.jaut.2019.102317.
    PubMed     Abstract available


  107. KARAGIANNI P, Tzioufas AG
    Epigenetic perspectives on systemic autoimmune disease.
    J Autoimmun. 2019 Aug 14:102315. doi: 10.1016/j.jaut.2019.102315.
    PubMed     Abstract available


  108. TAYLOR S, Pieri K, Nanni P, Tica J, et al
    Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
    J Autoimmun. 2019 Aug 8:102309. doi: 10.1016/j.jaut.2019.102309.
    PubMed     Abstract available


  109. FRESQUET M, Rhoden SJ, Jowitt TA, McKenzie EA, et al
    Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain.
    J Autoimmun. 2019 Aug 5:102308. doi: 10.1016/j.jaut.2019.102308.
    PubMed     Abstract available


  110. XOURGIA E, Tektonidou MG
    Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications.
    J Autoimmun. 2019 Aug 1:102311. doi: 10.1016/j.jaut.2019.102311.
    PubMed     Abstract available


    July 2019
  111. KOLB H, Burkart V
    Chaperones may cause the focus of diabetes autoimmunity on distinct (pro)insulin peptides.
    J Autoimmun. 2019 Jul 18:102304. doi: 10.1016/j.jaut.2019.102304.
    PubMed     Abstract available


  112. SHIN JI, Lee KH, Joo YH, Lee JM, et al
    Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
    J Autoimmun. 2019 Jul 17:102299. doi: 10.1016/j.jaut.2019.
    PubMed     Abstract available


  113. PACHECO Y, Acosta-Ampudia Y, Monsalve DM, Chang C, et al
    Bystander activation and autoimmunity.
    J Autoimmun. 2019 Jul 17:102301. doi: 10.1016/j.jaut.2019.
    PubMed     Abstract available


  114. MEIER HCS, Parks CG, Liu HB, Sandler DP, et al
    Cellular aging over 13 years associated with incident antinuclear antibody positivity in the Baltimore Longitudinal Study of Aging.
    J Autoimmun. 2019 Jul 11. pii: S0896-8411(19)30210.
    PubMed     Abstract available


  115. GOKHALE AS, Gangaplara A, Lopez-Occasio M, Thornton AM, et al
    Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity.
    J Autoimmun. 2019 Jul 8. pii: S0896-8411(19)30280.
    PubMed     Abstract available


  116. EL SHIKH MEM, El Sayed R, Nerviani A, Goldmann K, et al
    Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis.
    J Autoimmun. 2019 Jul 2. pii: S0896-8411(19)30200.
    PubMed     Abstract available


    June 2019
  117. ZENTSOVA I, Parackova Z, Kayserova J, Palova-Jelinkova L, et al
    Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients.
    J Autoimmun. 2019 Jun 27. pii: S0896-8411(19)30191.
    PubMed     Abstract available


  118. PINETON DE CHAMBRUN M, Larcher R, Pene F, Argaud L, et al
    CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.
    J Autoimmun. 2019 Jun 25. pii: S0896-8411(19)30295.
    PubMed     Abstract available


  119. TSAI HC, Nguyen K, Hashemi E, Engleman E, et al
    Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation.
    J Autoimmun. 2019 Jun 12. pii: S0896-8411(19)30209.
    PubMed     Abstract available


  120. ALVAREZ-SIERRA D, Marin-Sanchez A, Ruiz-Blazquez P, de Jesus Gil C, et al
    Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity.
    J Autoimmun. 2019 Jun 7. pii: S0896-8411(19)30156.
    PubMed     Abstract available


  121. SAINT-MARTIN M, Pieters A, Dechelotte B, Malleval C, et al
    Impact of anti-CASPR2 autoantibodies from patients with autoimmune encephalitis on CASPR2/TAG-1 interaction and Kv1 expression.
    J Autoimmun. 2019 Jun 5. pii: S0896-8411(19)30079.
    PubMed     Abstract available


  122. TENSPOLDE M, Zimmermann K, Weber LC, Hapke M, et al
    Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    J Autoimmun. 2019 Jun 5. pii: S0896-8411(19)30165.
    PubMed     Abstract available


  123. YAO L, Zhou L, Xuan Y, Zhang P, et al
    The proteasome activator REGgamma counteracts immunoproteasome expression and autoimmunity.
    J Autoimmun. 2019 Jun 3. pii: S0896-8411(19)30137.
    PubMed     Abstract available


    May 2019
  124. DAS T, Bergen IM, Koudstaal T, van Hulst JAC, et al
    DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
    J Autoimmun. 2019 May 28. pii: S0896-8411(19)30002.
    PubMed     Abstract available


  125. WILLIAMS A, Grantz K, Seeni I, Robledo C, et al
    Obstetric and neonatal complications among women with autoimmune disease.
    J Autoimmun. 2019 May 27. pii: S0896-8411(19)30111.
    PubMed     Abstract available


  126. GUO C, Fu R, Zhou M, Wang S, et al
    Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.
    J Autoimmun. 2019 May 24. pii: S0896-8411(19)30243.
    PubMed     Abstract available


  127. DE BOYSSON H, Liozon E, Espitia O, Daumas A, et al
    Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis.
    J Autoimmun. 2019 May 23. pii: S0896-8411(19)30106.
    PubMed     Abstract available


  128. HUYNH M, Eggenhuizen PJ, Olson GL, Rao NB, et al
    HLA-DR15-specific inhibition attenuates autoreactivity to the Goodpasture antigen.
    J Autoimmun. 2019 May 16. pii: S0896-8411(18)30665.
    PubMed     Abstract available


  129. PATSOURAS MD, Karagianni P, Kogionou P, Vlachoyiannopoulos PG, et al
    Differential CpG methylation of the promoter of interleukin 8 and the first intron of tissue factor in Antiphospholipid syndrome.
    J Autoimmun. 2019 May 15. pii: S0896-8411(19)30124.
    PubMed     Abstract available


  130. STREMSKA ME, Dai C, Venkatadri R, Wang H, et al
    IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent.
    J Autoimmun. 2019 May 15. pii: S0896-8411(19)30131.
    PubMed     Abstract available


  131. MATTAPALLIL MJ, Kielczewski JL, Zarate-Blades CR, St Leger AJ, et al
    Interleukin 22 ameliorates neuropathology and protects from central nervous system autoimmunity.
    J Autoimmun. 2019 May 9. pii: S0896-8411(18)30668.
    PubMed     Abstract available


  132. RODRIGUEZ Y, Vatti N, Ramirez-Santana C, Chang C, et al
    Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.
    J Autoimmun. 2019 May 6. pii: S0896-8411(19)30043.
    PubMed     Abstract available


  133. BRONGE M, Ruhrmann S, Carvalho-Queiroz C, Nilsson OB, et al
    Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis.
    J Autoimmun. 2019 May 1. pii: S0896-8411(19)30036.
    PubMed     Abstract available


    April 2019
  134. TERZIROLI BERETTA-PICCOLI B, Di Bartolomeo C, Deleonardi G, Grondona AG, et al
    Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents.
    J Autoimmun. 2019 Apr 29. pii: S0896-8411(19)30186.
    PubMed     Abstract available


  135. SEVERA M, Rizzo F, Srinivasan S, Di Dario M, et al
    A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.
    J Autoimmun. 2019 Apr 29. pii: S0896-8411(19)30094.
    PubMed     Abstract available


  136. LIU B, Gu Y, Pei S, Peng Y, et al
    Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE).
    J Autoimmun. 2019 Apr 26. pii: S0896-8411(19)30063.
    PubMed     Abstract available


  137. PIKET E, Zheleznyakova GY, Kular L, Jagodic M, et al
    Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.
    J Autoimmun. 2019 Apr 20. pii: S0896-8411(19)30129.
    PubMed     Abstract available


  138. BETTERIDGE Z, Tansley S, Shaddick G, Chinoy H, et al
    Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    J Autoimmun. 2019 Apr 13. pii: S0896-8411(19)30100.
    PubMed     Abstract available


    March 2019
  139. ERDEI E, Shuey C, Miller C, Pacheco B, et al
    Elevated autoimmunity in residents living near abandoned uranium mine sites on the Navajo Nation.
    J Autoimmun. 2019 Mar 13. pii: S0896-8411(18)30700.
    PubMed     Abstract available


  140. XIAO N, Wei J, Xu S, Du H, et al
    cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model.
    J Autoimmun. 2019 Mar 11. pii: S0896-8411(19)30035.
    PubMed     Abstract available


  141. WENDEL S, Venhoff N, Frye BC, May AM, et al
    Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two cases.
    J Autoimmun. 2019 Mar 9. pii: S0896-8411(18)30742.
    PubMed     Abstract available


  142. BING SJ, Shemesh I, Chong WP, Horai R, et al
    AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
    J Autoimmun. 2019 Mar 7. pii: S0896-8411(19)30020.
    PubMed     Abstract available


  143. YAMAMOTO E, Jorgensen TN
    Immunological effects of vitamin D and their relations to autoimmunity.
    J Autoimmun. 2019 Mar 7. pii: S0896-8411(19)30033.
    PubMed     Abstract available


    February 2019
  144. HEINRICH MJ, Purcell CA, Pruijssers AJ, Zhao Y, et al
    Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis.
    J Autoimmun. 2019 Feb 27. pii: S0896-8411(18)30699.
    PubMed     Abstract available


  145. SHEMER A, Willis R, Gonzalez EB, Romay-Penabad Z, et al
    Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome.
    J Autoimmun. 2019 Feb 20. pii: S0896-8411(18)30721.
    PubMed     Abstract available


  146. AMAYA-URIBE L, Rojas M, Azizi G, Anaya JM, et al
    Primary immunodeficiency and autoimmunity: A comprehensive review.
    J Autoimmun. 2019 Feb 19. pii: S0896-8411(18)30734.
    PubMed     Abstract available


  147. LONG D, Chen Y, Wu H, Zhao M, et al
    Clinical significance and immunobiology of IL-21 in autoimmunity.
    J Autoimmun. 2019 Feb 14. pii: S0896-8411(19)30049.
    PubMed     Abstract available


  148. PARIENTE A, Guedon A, Alamowitch S, Thietart S, et al
    Ischemic stroke in giant-cell arteritis: French retrospective study.
    J Autoimmun. 2019 Feb 5. pii: S0896-8411(18)30735.
    PubMed     Abstract available


    January 2019
  149. CROCI S, Bonacini M, Muratore F, Caruso A, et al
    The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis.
    J Autoimmun. 2019 Jan 9. pii: S0896-8411(18)30549.
    PubMed     Abstract available


  150. BROADLEY J, Seneviratne U, Beech P, Buzzard K, et al
    Prognosticating autoimmune encephalitis: A systematic review.
    J Autoimmun. 2019;96:24-34.
    PubMed     Abstract available


    December 2018
  151. VILLEGAS JA, Bayer AC, Ider K, Bismuth J, et al
    Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis.
    J Autoimmun. 2018 Dec 18. pii: S0896-8411(18)30607.
    PubMed     Abstract available


  152. SIMAKOU T, Butcher JP, Reid S, Henriquez FL, et al
    Alopecia areata: A multifactorial autoimmune condition.
    J Autoimmun. 2018 Dec 15. pii: S0896-8411(18)30584.
    PubMed     Abstract available


  153. QURESHI MS, Alsughayyir J, Chhabra M, Ali JM, et al
    Germinal center humoral autoimmunity independently mediates progression of allograft vasculopathy.
    J Autoimmun. 2018 Dec 6. pii: S0896-8411(18)30453.
    PubMed     Abstract available


  154. PICONESE S, Cammarata I, Barnaba V
    Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity.
    J Autoimmun. 2018;95:58-68.
    PubMed     Abstract available


  155. ROJAS M, Restrepo-Jimenez P, Monsalve DM, Pacheco Y, et al
    Molecular mimicry and autoimmunity.
    J Autoimmun. 2018;95:100-123.
    PubMed     Abstract available


    November 2018
  156. MOLANO-GONZALEZ N, Rojas M, Monsalve DM, Pacheco Y, et al
    Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity.
    J Autoimmun. 2018 Nov 17. pii: S0896-8411(18)30532.
    PubMed     Abstract available


  157. POSTIGO-FERNANDEZ J, Creusot RJ
    A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in Type 1 diabetes.
    J Autoimmun. 2018 Nov 17. pii: S0896-8411(18)30523.
    PubMed     Abstract available


  158. FAVA A, Petri M
    Systemic lupus erythematosus: Diagnosis and clinical management.
    J Autoimmun. 2018 Nov 15. pii: S0896-8411(18)30521.
    PubMed     Abstract available


  159. PETERSON LB, Bell CJM, Howlett SK, Pekalski ML, et al
    A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
    J Autoimmun. 2018 Nov 13. pii: S0896-8411(18)30423.
    PubMed     Abstract available


  160. VAN DER MEULEN TA, Harmsen HJM, Vila AV, Kurilshikov A, et al
    Shared gut, but distinct oral microbiota composition in primary Sjogren's syndrome and systemic lupus erythematosus.
    J Autoimmun. 2018 Nov 9. pii: S0896-8411(18)30524.
    PubMed     Abstract available


  161. TAUBERT R, Hupa-Breier KL, Jaeckel E, Manns MP, et al
    Novel therapeutic targets in autoimmune hepatitis.
    J Autoimmun. 2018 Nov 3. pii: S0896-8411(18)30601.
    PubMed     Abstract available


  162. KERKAR N, Vergani D
    De novo autoimmune hepatitis -is this different in adults compared to children?
    J Autoimmun. 2018 Nov 2. pii: S0896-8411(18)30600.
    PubMed     Abstract available


  163. CURRAN CS, Gupta S, Sanz I, Sharon E, et al
    PD-1 immunobiology in systemic lupus erythematosus.
    J Autoimmun. 2018 Nov 2. pii: S0896-8411(18)30408.
    PubMed     Abstract available


  164. TERZIROLI BERETTA-PICCOLI B, Ripellino P, Gobbi C, Cerny A, et al
    Autoimmune liver disease serology in acute hepatitis E virus infection.
    J Autoimmun. 2018;94:1-6.
    PubMed     Abstract available


    October 2018
  165. KARA S, Pirela-Morillo GA, Gilliam CT, Wilson GD, et al
    Identification of novel susceptibility genes associated with seven autoimmune disorders using whole genome molecular interaction networks.
    J Autoimmun. 2018 Oct 31. pii: S0896-8411(18)30508.
    PubMed     Abstract available


  166. BAERT L, Manfroi B, Casez O, Sturm N, et al
    The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
    J Autoimmun. 2018 Oct 30. pii: S0896-8411(18)30597.
    PubMed     Abstract available


  167. FLOREANI A, Restrepo-Jimenez P, Secchi MF, De Martin S, et al
    Etiopathogenesis of autoimmune hepatitis.
    J Autoimmun. 2018 Oct 29. pii: S0896-8411(18)30522.
    PubMed     Abstract available


  168. TERZIROLI BERETTA-PICCOLI B, Mieli-Vergani G, Vergani D
    The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
    J Autoimmun. 2018 Oct 23. pii: S0896-8411(18)30518.
    PubMed     Abstract available


  169. TERZIROLI BERETTA-PICCOLI B, Vergani D, Mieli-Vergani G
    Autoimmune sclerosing cholangitis: Evidence and open questions.
    J Autoimmun. 2018 Oct 23. pii: S0896-8411(18)30539.
    PubMed     Abstract available


  170. SOKOLLIK C, McLin VA, Vergani D, Terziroli Beretta-Piccoli B, et al
    Juvenile autoimmune hepatitis: A comprehensive review.
    J Autoimmun. 2018 Oct 18. pii: S0896-8411(18)30579.
    PubMed     Abstract available


  171. LUNDTOFT C, Seyfarth J, Oberstrass S, Rosenbauer J, et al
    Autoimmunity risk- and protection-associated IL7RA genetic variants differentially affect soluble and membrane IL-7Ralpha expression.
    J Autoimmun. 2018 Oct 17. pii: S0896-8411(18)30588.
    PubMed     Abstract available


  172. MA HD, Zhao ZB, Ma WT, Liu QZ, et al
    Gut microbiota translocation promotes autoimmune cholangitis.
    J Autoimmun. 2018 Oct 16. pii: S0896-8411(18)30459.
    PubMed     Abstract available


  173. LIANG W, Zhang J, Saint-Martin M, Xu F, et al
    Structural mapping of hot spots within human CASPR2 discoidin domain for autoantibody recognition.
    J Autoimmun. 2018 Oct 15. pii: S0896-8411(18)30294.
    PubMed     Abstract available


  174. ALPER CA, Larsen CE, Trautwein MR, Alford DR, et al
    A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes.
    J Autoimmun. 2018 Oct 8. pii: S0896-8411(18)30427.
    PubMed     Abstract available


  175. JOSEPH S, George NI, Green-Knox B, Treadwell EL, et al
    Epigenome-wide association study of peripheral blood mononuclear cells in systemic lupus erythematosus: Identifying DNA methylation signatures associated with interferon-related genes based on ethnicity and SLEDAI.
    J Autoimmun. 2018 Oct 6. pii: S0896-8411(18)30352.
    PubMed     Abstract available


    September 2018
  176. HSUEH YH, Chen HW, Syu BJ, Lin CI, et al
    Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis.
    J Autoimmun. 2018 Sep 28. pii: S0896-8411(18)30435.
    PubMed     Abstract available


  177. AMMITZBOLL C, von Essen MR, Bornsen L, Petersen ER, et al
    GPR15(+) T cells are Th17 like, increased in smokers and associated with multiple sclerosis.
    J Autoimmun. 2018 Sep 20. pii: S0896-8411(18)30350.
    PubMed     Abstract available


  178. BONAM SR, Wang F, Muller S
    Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option.
    J Autoimmun. 2018 Sep 12. pii: S0896-8411(18)30437.
    PubMed     Abstract available


  179. THIEL J, Alter C, Luppus S, Eckstein A, et al
    MicroRNA-183 and microRNA-96 are associated with autoimmune responses by regulating T cell activation.
    J Autoimmun. 2018 Sep 7. pii: S0896-8411(18)30302.
    PubMed     Abstract available


  180. RUFFATTI A, De Silvestro G, Marson P, Tonello M, et al
    Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.
    J Autoimmun. 2018;93:124-130.
    PubMed     Abstract available


  181. YE J, Richardson TG, McArdle WL, Relton CL, et al
    Identification of loci where DNA methylation potentially mediates genetic risk of type 1 diabetes.
    J Autoimmun. 2018;93:66-75.
    PubMed     Abstract available


    August 2018
  182. KUMAR P, Bhattacharya P, Prabhakar BS
    A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
    J Autoimmun. 2018 Aug 30. pii: S0896-8411(18)30407.
    PubMed     Abstract available


  183. WOHLERS I, Bertram L, Lill CM
    Evidence for a potential role of miR-1908-5p and miR-3614-5p in autoimmune disease risk using integrative bioinformatics.
    J Autoimmun. 2018 Aug 21. pii: S0896-8411(18)30119.
    PubMed     Abstract available


  184. ZHANG L, Sosinowski T, Aaron R, Cepeda JR, et al
    Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
    J Autoimmun. 2018 Aug 16. pii: S0896-8411(18)30251.
    PubMed     Abstract available


  185. LOMBARDI A, Tsomos E, Hammerstad SS, Tomer Y, et al
    Interferon alpha: The key trigger of type 1 diabetes.
    J Autoimmun. 2018 Aug 13. pii: S0896-8411(18)30323.
    PubMed     Abstract available


  186. LU D, Song J, Sun Y, Qi F, et al
    Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders.
    J Autoimmun. 2018 Aug 9. pii: S0896-8411(18)30333.
    PubMed     Abstract available


    July 2018
  187. NAHAL SK, Selmi C, Gershwin ME
    Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus.
    J Autoimmun. 2018 Jul 27. pii: S0896-8411(18)30280.
    PubMed     Abstract available


  188. RIPOLL VM, Pregnolato F, Mazza S, Bodio C, et al
    Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome.
    J Autoimmun. 2018 Jul 19. pii: S0896-8411(18)30300.
    PubMed     Abstract available


  189. HARTWELL BL, Pickens CJ, Leon M, Northrup L, et al
    Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis.
    J Autoimmun. 2018 Jul 12. pii: S0896-8411(18)30181.
    PubMed     Abstract available


  190. LI Q, Wu H, Liao W, Zhao M, et al
    A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
    J Autoimmun. 2018 Jul 11. pii: S0896-8411(18)30355.
    PubMed     Abstract available


  191. GELB S, Stock AD, Anzi S, Putterman C, et al
    Mechanisms of neuropsychiatric lupus: The relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier.
    J Autoimmun. 2018;91:34-44.
    PubMed     Abstract available


    June 2018
  192. ALEXANDER T, Farge D, Badoglio M, Lindsay JO, et al
    Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms.
    J Autoimmun. 2018 Jun 19. pii: S0896-8411(18)30182.
    PubMed     Abstract available


    May 2018
  193. DINSE GE, Parks CG, Meier HCS, Co CA, et al
    Prescription medication use and antinuclear antibodies in the United States, 1999-2004.
    J Autoimmun. 2018 May 17. pii: S0896-8411(18)30133.
    PubMed     Abstract available


  194. CERVERA R, Rodriguez-Pinto I, Espinosa G
    The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review.
    J Autoimmun. 2018 May 17. pii: S0896-8411(18)30248.
    PubMed     Abstract available


  195. HINTERMANN E, Bayer M, Conti CB, Fuchs S, et al
    Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice.
    J Autoimmun. 2018 May 9. pii: S0896-8411(18)30088.
    PubMed     Abstract available


    April 2018
  196. GHRAIEB A, Keren A, Ginzburg A, Ullmann Y, et al
    iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata.
    J Autoimmun. 2018 Apr 18. pii: S0896-8411(17)30541.
    PubMed     Abstract available


  197. BODEWES ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, et al
    TBK1: A key regulator and potential treatment target for interferon positive Sjogren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    J Autoimmun. 2018 Apr 16. pii: S0896-8411(17)30804.
    PubMed     Abstract available


  198. KRAAIJ T, Kamerling SWA, de Rooij ENM, van Daele PLA, et al
    The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.
    J Autoimmun. 2018 Apr 7. pii: S0896-8411(18)30083.
    PubMed     Abstract available


    March 2018
  199. LEWIS MJ, McAndrew MB, Wheeler C, Workman N, et al
    Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus.
    J Autoimmun. 2018 Mar 22. pii: S0896-8411(18)30023.
    PubMed     Abstract available


  200. ZHAO K, Du J, Peng Y, Li P, et al
    LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathways.
    J Autoimmun. 2018 Mar 7. pii: S0896-8411(17)30780.
    PubMed     Abstract available


  201. HUA Y, Shen M, McDonald C, Yao Q, et al
    Autophagy dysfunction in autoinflammatory diseases.
    J Autoimmun. 2018;88:11-20.
    PubMed     Abstract available


  202. SAMUDRA AN, Dwyer KM, Selan C, Freddi S, et al
    CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages.
    J Autoimmun. 2018;88:131-138.
    PubMed     Abstract available


  203. SKOPELJA-GARDNER S, Jones JD, Rigby WFC
    "NETtling" the host: Breaking of tolerance in chronic inflammation and chronic infection.
    J Autoimmun. 2018;88:1-10.
    PubMed     Abstract available


    February 2018
  204. ZHANG L, Li Y, Qiu W, Bell BA, et al
    Targeting CD6 for the treatment of experimental autoimmune uveitis.
    J Autoimmun. 2018 Feb 19. pii: S0896-8411(17)30823.
    PubMed     Abstract available


  205. CHIGHIZOLA CB, Pregnolato F, Andreoli L, Bodio C, et al
    Beyond thrombosis: Anti-beta2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.
    J Autoimmun. 2018 Feb 14. pii: S0896-8411(17)30698.
    PubMed     Abstract available


  206. CHIGHIZOLA CB, Andreoli L, Gerosa M, Tincani A, et al
    The treatment of anti-phospholipid syndrome: A comprehensive clinical approach.
    J Autoimmun. 2018 Feb 12. pii: S0896-8411(18)30054.
    PubMed     Abstract available


  207. HOUTMAN M, Shchetynsky K, Chemin K, Hensvold AH, et al
    T cells are influenced by a long non-coding RNA in the autoimmune associated PTPN2 locus.
    J Autoimmun. 2018 Feb 2. pii: S0896-8411(17)30795.
    PubMed     Abstract available


  208. KREBS CF, Panzer U
    Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases.
    J Autoimmun. 2018;87:61-68.
    PubMed     Abstract available


    January 2018
  209. STECK AK, Dong F, Frohnert BI, Waugh K, et al
    Predicting progression to diabetes in islet autoantibody positive children.
    J Autoimmun. 2018 Jan 27. pii: S0896-8411(17)30806.
    PubMed     Abstract available


  210. MCGINLEY AM, Edwards SC, Raverdeau M, Mills KHG, et al
    Th17cells, gammadelta T cells and their interplay in EAE and multiple sclerosis.
    J Autoimmun. 2018 Jan 21. pii: S0896-8411(18)30007.
    PubMed     Abstract available


  211. DASH B, Shapiro MJ, Chung JY, Romero Arocha S, et al
    Treg-specific deletion of NKAP results in severe, systemic autoimmunity due to peripheral loss of Tregs.
    J Autoimmun. 2018 Jan 20. pii: S0896-8411(17)30556.
    PubMed     Abstract available


  212. GIANFRAN C, Pisapia L, Picascia S, Strazzullo M, et al
    Expression level of risk genes of MHC class II is a susceptibility factor for autoimmunity: New insights.
    J Autoimmun. 2018 Jan 10. pii: S0896-8411(17)30626.
    PubMed     Abstract available


  213. SHARMA A, Liu X, Hadley D, Hagopian W, et al
    Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
    J Autoimmun. 2018 Jan 5. pii: S0896-8411(17)30739.
    PubMed     Abstract available


  214. EVANGELISTA F, Roth AJ, Prisayanh P, Temple BR, et al
    Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope.
    J Autoimmun. 2018 Jan 4. pii: S0896-8411(17)30766.
    PubMed     Abstract available


  215. JAMIN A, Berthelot L, Couderc A, Chemouny JM, et al
    Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice.
    J Autoimmun. 2018 Jan 4. pii: S0896-8411(17)30684.
    PubMed     Abstract available


  216. YAO Y, Li L, Yang SH, Gao CY, et al
    CD8(+) T cells and IFN-gamma induce autoimmune myelofibrosis in mice.
    J Autoimmun. 2018 Jan 4. pii: S0896-8411(17)30763.
    PubMed     Abstract available


  217. GENSTERBLUM E, Renauer P, Coit P, Strickland FM, et al
    CD4+CD28+KIR+CD11a(hi) T cells correlate with disease activity and are characterized by a pro-inflammatory epigenetic and transcriptional profile in lupus patients.
    J Autoimmun. 2018;86:19-28.
    PubMed     Abstract available


  218. CHAVEZ-VALENCIA RA, Chiaroni-Clarke RC, Martino DJ, Munro JE, et al
    The DNA methylation landscape of CD4(+) T cells in oligoarticular juvenile idiopathic arthritis.
    J Autoimmun. 2018;86:29-38.
    PubMed     Abstract available


    December 2017
  219. STADHOUDERS R, Lubberts E, Hendriks RW
    A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
    J Autoimmun. 2017 Dec 21. pii: S0896-8411(17)30803.
    PubMed     Abstract available


  220. PRASAD S, Neef T, Xu D, Podojil JR, et al
    Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.
    J Autoimmun. 2017 Dec 16. pii: S0896-8411(17)30754.
    PubMed     Abstract available


  221. SMITH MJ, Rihanek M, Coleman BM, Gottlieb PA, et al
    Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients.
    J Autoimmun. 2017 Dec 9. pii: S0896-8411(17)30616.
    PubMed     Abstract available


  222. KINDT ASD, Fuerst RW, Knoop J, Laimighofer M, et al
    Allele-specific methylation of type 1 diabetes susceptibility genes.
    J Autoimmun. 2017 Dec 7. pii: S0896-8411(17)30598.
    PubMed     Abstract available


  223. PAPOTTO PH, Reinhardt A, Prinz I, Silva-Santos B, et al
    Innately versatile: gammadelta17 T cells in inflammatory and autoimmune diseases.
    J Autoimmun. 2017 Dec 1. pii: S0896-8411(17)30768.
    PubMed     Abstract available


  224. COLOTTA F, Jansson B, Bonelli F
    Modulation of inflammatory and immune responses by vitamin D.
    J Autoimmun. 2017;85:78-97.
    PubMed     Abstract available


  225. PROOST P, Struyf S, Van Damme J, Fiten P, et al
    Chemokine isoforms and processing in inflammation and immunity.
    J Autoimmun. 2017;85:45-57.
    PubMed     Abstract available


    November 2017
  226. TAN AH, Sanny A, Ng SW, Ho YS, et al
    Excessive interferon-alpha signaling in autoimmunity alters glycosphingolipid processing in B cells.
    J Autoimmun. 2017 Nov 27. pii: S0896-8411(17)30603.
    PubMed     Abstract available


  227. RODRIGUEZ Y, Rojas M, Gershwin ME, Anaya JM, et al
    Tick-borne diseases and autoimmunity: A comprehensive review.
    J Autoimmun. 2017 Nov 25. pii: S0896-8411(17)30625.
    PubMed     Abstract available


  228. OKADA Y, Ochi H, Fujii C, Hashi Y, et al
    Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production.
    J Autoimmun. 2017 Nov 13. pii: S0896-8411(17)30534.
    PubMed     Abstract available


  229. ABBOTT JK, Huoh YS, Reynolds PR, Yu L, et al
    Dominant-negative loss of function arises from a second, more frequent variant within the SAND domain of autoimmune regulator (AIRE).
    J Autoimmun. 2017 Nov 9. pii: S0896-8411(17)30579.
    PubMed     Abstract available


    October 2017
  230. MAVRAGANI CP, Nezos A, Sagalovskiy I, Seshan S, et al
    Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
    J Autoimmun. 2017 Oct 23. pii: S0896-8411(17)30610.
    PubMed     Abstract available


  231. KALLURI SR, Grummel V, Hracsko Z, Pongratz V, et al
    Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients.
    J Autoimmun. 2017 Oct 20. pii: S0896-8411(17)30587.
    PubMed     Abstract available


  232. NICOL B, Salou M, Vogel I, Garcia A, et al
    An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis.
    J Autoimmun. 2017 Oct 17. pii: S0896-8411(17)30619.
    PubMed     Abstract available


  233. VARADE J, Wang N, Lim CK, Zhang T, et al
    Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis.
    J Autoimmun. 2017 Oct 13. pii: S0896-8411(17)30565.
    PubMed     Abstract available


  234. LING Q, Lu J, Li J, Xu Q, et al
    Risk of beta-cell autoimmunity presence for progression to type 1 diabetes: A systematic review and meta-analysis.
    J Autoimmun. 2017 Oct 5. pii: S0896-8411(17)30568.
    PubMed     Abstract available


    September 2017
  235. KHARE P, Challa DK, Devanaboyina SC, Velmurugan R, et al
    Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model.
    J Autoimmun. 2017 Sep 27. pii: S0896-8411(17)30155.
    PubMed     Abstract available


  236. GOSCHL L, Preglej T, Hamminger P, Bonelli M, et al
    A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis.
    J Autoimmun. 2017 Sep 27. pii: S0896-8411(17)30595.
    PubMed     Abstract available


  237. DIEBOLD M, Sievers C, Bantug G, Sanderson N, et al
    Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.
    J Autoimmun. 2017 Sep 25. pii: S0896-8411(17)30531.
    PubMed     Abstract available


  238. LO MS, Towne M, VanNoy GE, Brownstein CA, et al
    Monogenic Hashimoto thyroiditis associated with a variant in the thyroglobulin (TG) gene.
    J Autoimmun. 2017 Sep 21. pii: S0896-8411(17)30528.
    PubMed     Abstract available


  239. LYNCH KF, Lee HS, Torn C, Vehik K, et al
    Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident beta-cell autoantibodies.
    J Autoimmun. 2017 Sep 20. pii: S0896-8411(17)30558.
    PubMed     Abstract available


  240. IACCARINO L, Andreoli L, Bocci EB, Bortoluzzi A, et al
    Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.
    J Autoimmun. 2017 Sep 18. pii: S0896-8411(17)30438.
    PubMed     Abstract available


  241. NISHIJIMA H, Kajimoto T, Matsuoka Y, Mouri Y, et al
    Paradoxical development of polymyositis-like autoimmunity through augmented expression of autoimmune regulator (AIRE).
    J Autoimmun. 2017 Sep 17. pii: S0896-8411(17)30482.
    PubMed     Abstract available


    August 2017
  242. HARBIGE J, Eichmann M, Peakman M
    New insights into non-conventional epitopes as T cell targets: The missing link for breaking immune tolerance in autoimmune disease?
    J Autoimmun. 2017 Aug 10. pii: S0896-8411(17)30389.
    PubMed     Abstract available


    July 2017
  243. SOZZANI S, Del Prete A, Bosisio D
    Dendritic cell recruitment and activation in autoimmunity.
    J Autoimmun. 2017 Jul 31. pii: S0896-8411(17)30502.
    PubMed     Abstract available


  244. WU DJ, Gu R, Sarin R, Zavodovskaya R, et al
    Corrigendum to "Autophagy-linked FYVE containing protein WDFY3 interacts with TRAF6 and modulates RANKL-induced osteoclastogenesis" [J. Autoimmun. 73C (2016) 73-84].
    J Autoimmun. 2017 Jul 27. pii: S0896-8411(17)30436.
    PubMed    


  245. VARKI A
    Are humans prone to autoimmunity? Implications from evolutionary changes in hominin sialic acid biology.
    J Autoimmun. 2017 Jul 26. pii: S0896-8411(17)30479.
    PubMed     Abstract available


  246. FERREIRA RC, Simons HZ, Thompson WS, Rainbow DB, et al
    Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity.
    J Autoimmun. 2017 Jul 23. pii: S0896-8411(17)30324.
    PubMed     Abstract available


  247. MA WT, Chang C, Gershwin ME, Lian ZX, et al
    Development of autoantibodies precedes clinical manifestations of autoimmune diseases: A comprehensive review.
    J Autoimmun. 2017 Jul 21. pii: S0896-8411(17)30354.
    PubMed     Abstract available


  248. SICA A, Massarotti M
    Myeloid suppressor cells in cancer and autoimmunity.
    J Autoimmun. 2017 Jul 17. pii: S0896-8411(17)30481.
    PubMed     Abstract available


  249. RYDEN AK, Perdue NR, Pagni PP, Gibson CB, et al
    Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes.
    J Autoimmun. 2017 Jul 12. pii: S0896-8411(17)30259.
    PubMed     Abstract available


    June 2017
  250. TANSLEY SL, Simou S, Shaddick G, Betteridge ZE, et al
    Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.
    J Autoimmun. 2017 Jun 26. pii: S0896-8411(17)30170.
    PubMed     Abstract available


  251. GIANFREDA D, Quaglini S, Frontini G, Raffiotta F, et al
    Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis?
    J Autoimmun. 2017 Jun 21. pii: S0896-8411(17)30359.
    PubMed     Abstract available


  252. IFERGAN I, Davidson TS, Kebir H, Xu D, et al
    Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.
    J Autoimmun. 2017 Jun 19. pii: S0896-8411(17)30107.
    PubMed     Abstract available


  253. WATAD A, Azrielant S, Bragazzi NL, Sharif K, et al
    Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity.
    J Autoimmun. 2017 Jun 14. pii: S0896-8411(17)30313.
    PubMed     Abstract available


  254. GIANNELOU M, Mavragani CP
    Cardiovascular disease in systemic lupus erythematosus: A comprehensive update.
    J Autoimmun. 2017 Jun 9. pii: S0896-8411(17)30379.
    PubMed     Abstract available


  255. LOMBARDI A, Tomer Y
    Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress.
    J Autoimmun. 2017;80:48-55.
    PubMed     Abstract available


  256. SHIBATA A, Sugiura K, Furuta Y, Mukumoto Y, et al
    Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA.
    J Autoimmun. 2017;80:28-38.
    PubMed     Abstract available


  257. GILLIS CM, Zenatti PP, Mancardi DA, Beutier H, et al
    In vivo effector functions of high-affinity mouse IgG receptor FcgammaRI in disease and therapy models.
    J Autoimmun. 2017;80:95-102.
    PubMed     Abstract available


    May 2017
  258. MAMRUT S, Avidan N, Truffault F, Staun-Ram E, et al
    Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins.
    J Autoimmun. 2017 May 23. pii: S0896-8411(17)30130.
    PubMed     Abstract available


  259. LI S, Yang D, Peng T, Wu Y, et al
    Innate lymphoid cell-derived cytokines in autoimmune diseases.
    J Autoimmun. 2017 May 5. pii: S0896-8411(16)30325.
    PubMed     Abstract available


  260. SMITH S, Fernando T, Wu PW, Seo J, et al
    MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE.
    J Autoimmun. 2017;79:105-111.
    PubMed     Abstract available


  261. LEICHNER TM, Satake A, Harrison VS, Tanaka Y, et al
    Skin-derived TSLP systemically expands regulatory T cells.
    J Autoimmun. 2017;79:39-52.
    PubMed     Abstract available


  262. HULL CM, Nickolay LE, Estorninho M, Richardson MW, et al
    Generation of human islet-specific regulatory T cells by TCR gene transfer.
    J Autoimmun. 2017;79:63-73.
    PubMed     Abstract available


    April 2017
  263. GENERALI E, Ceribelli A, Stazi MA, Selmi C, et al
    Lessons learned from twins in autoimmune and chronic inflammatory diseases.
    J Autoimmun. 2017 Apr 18. pii: S0896-8411(17)30246.
    PubMed     Abstract available


  264. AUNE TM, Crooke PS 3rd, Patrick AE, Tossberg JT, et al
    Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants.
    J Autoimmun. 2017 Apr 15. pii: S0896-8411(17)30070.
    PubMed     Abstract available


  265. XIANG Z, Yang Y, Chang C, Lu Q, et al
    The epigenetic mechanism for discordance of autoimmunity in monozygotic twins.
    J Autoimmun. 2017 Apr 12. pii: S0896-8411(17)30241.
    PubMed     Abstract available


    March 2017
  266. AMARA K, Clay E, Yeo L, Ramskold D, et al
    B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis.
    J Autoimmun. 2017 Mar 24. pii: S0896-8411(16)30396.
    PubMed     Abstract available


  267. CHEN B, Sun L, Zhang X
    Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    J Autoimmun. 2017 Mar 22. pii: S0896-8411(17)30178.
    PubMed     Abstract available


  268. SAKAI T, Miyazaki T, Shin DM, Kim YS, et al
    DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.
    J Autoimmun. 2017 Mar 18. pii: S0896-8411(17)30024.
    PubMed     Abstract available


  269. OFTEDAL BE, Ardesjo Lundgren B, Hamm D, Gan PY, et al
    T cell receptor assessment in autoimmune disease requires access to the most adjacent immunologically active organ.
    J Autoimmun. 2017 Mar 15. pii: S0896-8411(16)30344.
    PubMed     Abstract available


  270. LIU CJ, Tsai CY, Chiang SH, Tang SJ, et al
    Triggering receptor expressed on myeloid cells-1 (TREM-1) deficiency augments BAFF production to promote lupus progression.
    J Autoimmun. 2017;78:92-100.
    PubMed     Abstract available


  271. KERSTEIN A, Schuler S, Cabral-Marques O, Fazio J, et al
    Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitis.
    J Autoimmun. 2017;78:79-91.
    PubMed     Abstract available


    February 2017
  272. CHEN Q, Liu Y, Lu A, Ni K, et al
    Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system.
    J Autoimmun. 2017;77:1-10.
    PubMed     Abstract available


  273. AUDIA S, Rossato M, Trad M, Samson M, et al
    B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia.
    J Autoimmun. 2017;77:89-95.
    PubMed     Abstract available


    October 2016
  274. KUHN C, Rezende RM, da Cunha AP, Valette F, et al
    Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.
    J Autoimmun. 2016 Oct 10. pii: S0896-8411(16)30204.
    PubMed     Abstract available


    September 2016
  275. ZERIF E, Maalem A, Gaudreau S, Guindi C, et al
    Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.
    J Autoimmun. 2016 Sep 12. pii: S0896-8411(16)30140.
    PubMed     Abstract available


    June 2016
  276. HAMEL Y, Mauvais FX, Pham HP, Kratzer R, et al
    A unique CD8+ T lymphocyte signature in pediatric type 1 diabetes.
    J Autoimmun. 2016 Jun 15. pii: S0896-8411(16)30081.
    PubMed     Abstract available


  277. BRAUDEAU C, Amouriaux K, Neel A, Herbreteau G, et al
    Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis.
    J Autoimmun. 2016;70:73-9.
    PubMed     Abstract available


  278. MESSINA N, Fulford T, O'Reilly L, Loh WX, et al
    The NF-kappaB transcription factor RelA is required for the tolerogenic function of Foxp3(+) regulatory T cells.
    J Autoimmun. 2016;70:52-62.
    PubMed     Abstract available


    May 2016
  279. KUHN C, Besancon A, Lemoine S, You S, et al
    Regulatory mechanisms of immune tolerance in type 1 diabetes and their failures.
    J Autoimmun. 2016 May 20. pii: S0896-8411(16)30053.
    PubMed     Abstract available


  280. GARYU JW, Meffre E, Cotsapas C, Herold KC, et al
    Progress and challenges for treating Type 1 diabetes.
    J Autoimmun. 2016 May 17. pii: S0896-8411(16)30036.
    PubMed     Abstract available


  281. MARRE ML, Profozich JL, Coneybeer JT, Geng X, et al
    Inherent ER stress in pancreatic islet beta cells causes self-recognition by autoreactive T cells in type 1 diabetes.
    J Autoimmun. 2016 May 9. pii: S0896-8411(16)30051.
    PubMed     Abstract available


    April 2016
  282. SAUNDERS D, Powers AC
    Replicative capacity of beta-cells and type 1 diabetes.
    J Autoimmun. 2016 Apr 28. pii: S0896-8411(16)30027.
    PubMed     Abstract available


  283. GITELMAN SE, Bluestone JA
    Regulatory T cell therapy for type 1 diabetes: May the force be with you.
    J Autoimmun. 2016 Apr 28. pii: S0896-8411(16)30024.
    PubMed     Abstract available


  284. KRISHNAMURTHY B, Selck C, Chee J, Jhala G, et al
    Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
    J Autoimmun. 2016 Apr 12. pii: S0896-8411(16)30031.
    PubMed     Abstract available


  285. EHLERS MR
    Strategies for clinical trials in type 1 diabetes.
    J Autoimmun. 2016 Apr 5. pii: S0896-8411(16)30021.
    PubMed     Abstract available


    March 2016
  286. TAI N, Wong FS, Wen L
    The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.
    J Autoimmun. 2016 Mar 24. pii: S0896-8411(16)30019.
    PubMed     Abstract available


  287. WILCOX NS, Rui J, Hebrok M, Herold KC, et al
    Life and death of beta cells in Type 1 diabetes: A comprehensive review.
    J Autoimmun. 2016 Mar 23. pii: S0896-8411(16)30003.
    PubMed     Abstract available


  288. BUCKNER JH, Nepom GT
    Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.
    J Autoimmun. 2016 Mar 3. pii: S0896-8411(16)30011.
    PubMed     Abstract available


    February 2016
  289. PAUN A, Yau C, Danska JS
    Immune recognition and response to the intestinal microbiome in type 1 diabetes.
    J Autoimmun. 2016 Feb 20. pii: S0896-8411(16)30006.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: